Shire Share Discussion Threads

[philanderer] 27/10/2017 13:15

EI , bit early by the look of it ...... time for a bacon sarnie :-)

[essentialinvestor] 27/10/2017 13:14

As I mentioned a couple of times be mindful of what happened on the last update,
spike Up, sold off aggressively.

[andyj] 27/10/2017 13:14

What is going on now?

[romeike] 27/10/2017 13:09

Been buying this share since it was a few quid. There's nothing wrong with their business. US market hates healthcare thanks to meddling politicians.

[steeplejack] 27/10/2017 13:08

HCM and Abcam are just further examples of the schizophrenic market. WildlyHCM and Abcam are just further examples of the schizophrenic market. Wildly overvalued. Abcam trades on a P/E of 50, HCM has a P/E over 200 (!), made a profit of just £12M last year. Shire? P/E of 9 and gets trashed."You're quite right of course but if one simply sticks to comparing ratios,you'd never buy a multi bagging biotech.

[ruethewhirl] 27/10/2017 12:58

Ornskov is bullish, hefty share purchases and great trading statement.

What's not to like?

[justiceforthemany] 27/10/2017 12:56

The 10% sell off in the past week was an absolute disgrace. Totally unjustified.

[justiceforthemany] 27/10/2017 12:55

Chief executive officer Flemming Ornskov said: "We are reiterating our 2017 full year guidance, and I look forward to updating you on the neuroscience strategic review by year end. I continue to be highly confident in the strength and durability of our business."

[romeike] 27/10/2017 12:53

Good results. Fixed market doesn't care. Analysts will find some excuse to trash company in call just like with GSK as they prep clients for another big rotation and cash in on shorts in the meantime. Wouldn't be surprised if Finance and Tech get hit hard and all of a sudden pharma is fashionable again.

[essentialinvestor] 27/10/2017 12:52

Good call paa.

[philanderer] 27/10/2017 12:49

Bought my other half back :-)

[justiceforthemany] 27/10/2017 12:47

Now where are those brokers with their BUY ratings and 6000p target prices?

[justiceforthemany] 27/10/2017 12:47

RSI in the US Nasdaq is already very low at 26 with Williams score of -95 = highly oversold already.

[paa65] 27/10/2017 12:44

Liking the look of the penant that has formed since the results today.Squeezing nicely then whoosh

[philanderer] 27/10/2017 12:33

Conference call at 2pm

[ruethewhirl] 27/10/2017 12:33

Maybe it'll kick on at the US open.

[swedeee] 27/10/2017 12:24

dont seem to be any skeletons in the closet here? very odd share price action

i also personally agree abcam is overvalued, but they do make sterling lab consumables (i work in the industry)

[justiceforthemany] 27/10/2017 12:17

There was $750M write down of intangibles and integration costs so NET INCOME for Q3 was actually $1.25Bn which means the adjusted EBITDA for full year remains around $4Bn

[ruethewhirl] 27/10/2017 12:17

Response a little tepid so far.

Doesn't add up.

Sell off seemed to be in anticipation of a fly in the ointment.

Correct me if I'm wrong, but there isn't one.

[justiceforthemany] 27/10/2017 12:13

Liabilities DOWN $3Bn year on year

[andyj] 27/10/2017 12:09

I wonder if the supply shortage was behind the sell off, but if it was it's past now.

[essentialinvestor] 27/10/2017 12:08

Out of those 3562 .

[essentialinvestor] 27/10/2017 12:05

Snap, but can't call the short term direction, added in any case 3490.